← Leaderboards
Dai Lu
University Of Connecticut Storrs
$1,843,851
Attributed
$5,531,554
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2016–22$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,531,554 · 2
By mechanism
UG3$2,903,097 · 1
R01$2,628,457 · 1
Top collaborators
- Aron H Lichtman6 shared
- Debra A Kendall5 shared
- Steven G. Kinsey1 shared
- Dana E Selley1 shared
- Feng Tao1 shared
Most similar at University Of Connecticut Storrs
Same institution · by research overlap
- Alexandros Makriyannis$48,379,340
- Debra A Kendall$6,803,425
- Xiang-Qun Xie$8,062,308
- Akiko Nishiyama$8,919,537
- Spiro Pavlopoulos$1,702,045
Others in their field
Top investigators on “Rewards”
- S. Claiborne Johnston · University Of California San Francisco$83,501,485
- Bruce R. Blazar · University Of Minnesota$67,782,274
- Adrian Hernandez · Duke University$50,769,596
- Muredach P Reilly · Columbia University Health Sciences$46,763,273
- Jennifer R Grandis · University Of Pittsburgh At Pittsburgh$44,486,622
- Karl Alexander Deisseroth · Stanford University$39,838,805
Research focus
RewardsPainPharmacologyCnr1 GeneResponseIn VivoPositive Allosteric ModulatorAgonistAnimal ModelCannabinoidsReceptorPropertyScaffoldPainful NeuropathyCannabimimeticsMolecularLeadLaboratoriesLigandsDesignMouse ModelMemoryBindingTranslating
Grant awards (7)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics$2,903,097
UG3 · FY2022 · NS · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$470,413
R01 · FY2020 · DA
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$478,136
R01 · FY2019 · DA
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$489,316
R01 · FY2018 · DA
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$157,998
R01 · FY2018 · DA
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$498,694
R01 · FY2017 · DA
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$533,900
R01 · FY2016 · DA